A study involving identical twins suggests alterations in immune cells called CD8 T-cells may be early drivers of ...

The awards celebrate the discovery of a new role for CD4 T cells in the cancer immune response and insights into autoimmune ...

Discover research by Hongbo Chi, PhD, that uncovers the interplay between organelles, nutrient-dependent signaling pathways ...

Glioblastoma is the most common and aggressive type of primary brain tumor, with an average survival rate of 15 months, ...

A cancer vaccine that had little success in clinical trials for patients with advanced tumors could potentially have efficacy ...

In an alarming discovery, researchers have uncovered a startling link between chronic stress and the progression of ...

The treatment also activated patients’ immune systems, with effector CD8+ and CD4+ T cells successfully infiltrating tumors, ...

Immatics, a biotech company working on promising cell-based immunotherapies for solid cancers, has a promising TCR-engineered ...

Aura Biosciences released early Phase 1 trial data on bel-sar for non-muscle-invasive bladder cancer, showing promising ...

CAR-T cell products’ quality control standards incorporate characterization, uniformity, and purity testing to ensure and ...